Pharmaceutical contribution to the prevention of levodopa-food interactions

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: HPS-033
• By: SANGRADOR RASERO, Ana María ()
• Co-author(s): Dr Víctor Fernández Martínez (Marqués de Valdecilla Universitary Hospital, Santander, Spain)
  Dr Marina Bàrbara Ramis Barceló, Hospital pharmacy
  Dr Ana María Sangrador Rasero, Hospital pharmacy
  Dr María Victoria Villacañas Palomares, Hospital pharmacy
  Dr Lorenzo Pérez-Periáñez Orrillo, Hospital pharmacy
  Dr Irene Aragón Gracia, Hospital pharmacy
  Dr Marta Valero Domínguez, Hospital pharmacy
  
• Abstract:

  PHARMACEUTICAL CONTRIBUTION TO THE PREVENTION OF
  LEVODOPA-FOOD INTERACTIONS
  
  INTRODUCTION/BACKGROUND: Levodopa is mainly absorbed in the small intestine through a transport mechanism also used by dietary amino acids; this competition may reduce its therapeutic effect. The fact sheet recommends its administration on an empty stomach or with a low..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login